Home › Asset managers › Compare 2025-2026 › ProShares vs Brighthouse
Note on Brighthouse: its funds did not all vote the same way on 12.0% of the 120,192 ballot items it voted. Those items are not in the percentage above; the ones it shares with this pair are listed under “Split votes”.
ProShares 2025-2026 · Brighthouse 2025-2026 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 24,952 | 14,314 | 100 | 10,538 | 99.3% | 84.9% |
| Board proposals | 23,126 | 13,204 | 92 | 9,830 | 99.3% | 85.0% |
| E&S shareholder proposals | 171 | 0 | 0 | 171 | n/a | 41.6% |
| Other items | 1,655 | 1,110 | 8 | 537 | 99.3% | 86.6% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
92 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | ProShares | Brighthouse |
|---|---|---|---|---|---|---|
| Autoliv, Inc. | May 7, 2026 | Election of Directors: Frederic Lissalde Director Elections |
Board | For | FOR 9 funds |
WITHHOLD 1 fund |
| B2GOLD CORP | June 4, 2026 | ADVISORY VOTE ON EXECUTIVE COMPENSATION APPROACH Say-on-Pay |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| Bankwell Financial Group, Inc. | May 20, 2026 | Election of Directors: Kevin D. Leitao Director Elections |
Board | For | FOR 9 funds |
WITHHOLD 1 fund |
| CENTESSA PHARMACEUTICALS PLC | June 12, 2026 | To authorize the Audit Committee to determine the Company's auditors' remuneration for the financial year ending December 31, 2026. Audit-related |
Board | For | FOR 2 funds |
ABSTAIN 1 fund |
| CENTESSA PHARMACEUTICALS PLC | June 12, 2026 | To ratify the re-appointment of KPMG LLP, a Delaware limited liability partnership, as the Company's independent registered public accounting firm, for the financial year ending December 31, 2026. Audit-related |
Board | For | FOR 2 funds |
ABSTAIN 1 fund |
| CENTESSA PHARMACEUTICALS PLC | June 12, 2026 | To re-appoint KPMG LLP, a United Kingdom entity, as UK statutory auditors of the Company, to hold office until the conclusion of the next meeting at which the Company's annual accounts and reports are laid before the Company. Audit-related |
Board | For | FOR 2 funds |
ABSTAIN 1 fund |
| CENTESSA PHARMACEUTICALS PLC | June 12, 2026 | To re-appoint as a director Brett Zbar, M.D., who retires by rotation in accordance with the Company's articles of association. Director Elections |
Board | For | FOR 2 funds |
ABSTAIN 1 fund |
| CENTESSA PHARMACEUTICALS PLC | June 12, 2026 | To re-appoint as a director Carol Stuckley, M.B.A., who retires by rotation in accordance with the Company's articles of association. Director Elections |
Board | For | FOR 2 funds |
ABSTAIN 1 fund |
| CHINA RESOURCES GAS GROUP LTD | May 28, 2026 | Approve Deloitte Touche Tohmatsu as Auditor and Authorize Board to Fix Their Remuneration Audit-related |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| CHINA RESOURCES GAS GROUP LTD | May 28, 2026 | Elect Law, Cheuk Kin Stephen as Director Director Elections |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| CHINA RESOURCES GAS GROUP LTD | May 28, 2026 | Elect Li Pok Yan as Director Director Elections |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| CODEXIS, INC. | June 17, 2026 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 10 funds |
ABSTAIN 1 fund |
| CODEXIS, INC. | June 17, 2026 | To ratify the selection by the Audit Committee of our Board of Directors of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 10 funds |
ABSTAIN 1 fund |
| CVS GROUP PLC | November 18, 2025 | Approve Remuneration Report Say-on-Pay |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| DMC GLOBAL INC. | May 13, 2026 | Advisory vote on executive compensation. Say-on-Pay |
Board | For | FOR 9 funds |
AGAINST 1 fund |
| DMC GLOBAL INC. | May 13, 2026 | Approval of the amendment and restatement of the Company's 2025 Omnibus Incentive Plan. Compensation |
Board | For | FOR 9 funds |
AGAINST 1 fund |
| ENGHOUSE SYSTEMS LTD | March 12, 2026 | ELECTION OF DIRECTOR: PAUL STOYAN Director Elections |
Board | For | FOR 1 fund |
WITHHOLD 1 fund |
| ENGHOUSE SYSTEMS LTD | March 12, 2026 | ELECTION OF DIRECTOR: PIERRE LASSONDE Director Elections |
Board | Not determined | FOR 1 fund |
WITHHOLD 1 fund |
| EURAZEO SA | May 6, 2026 | Approve Compensation of Olivier Millet, Management Board Member Until March 17, 2025 Say-on-Pay |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| EURAZEO SA | May 6, 2026 | Approve Compensation of Sophie Flak, Management Board Member Say-on-Pay |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| EURAZEO SA | May 6, 2026 | Approve Compensation of William Kadouch-Chassaing, Management Board Member Say-on-Pay |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| FIRST MAJESTIC SILVER CORPORATION | June 10, 2026 | ADVISORY VOTE ON EXECUTIVE COMPENSATION APPROACH Say-on-Pay |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| FRIEDRICH VORWERK GROUP SE | June 1, 2026 | APPROVE REMUNERATION REPORT Say-on-Pay |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| Figma, Inc. | June 2, 2026 | Election of Directors: Andrew Reed Director Elections |
Board | For | WITHHOLD 2 funds |
FOR 1 fund |
| Figma, Inc. | June 2, 2026 | Election of Directors: Danny Rimer Director Elections |
Board | For | WITHHOLD 2 funds |
FOR 1 fund |
| Figma, Inc. | June 2, 2026 | Election of Directors: Dylan Field Director Elections |
Board | For | WITHHOLD 2 funds |
FOR 1 fund |
| Figma, Inc. | June 2, 2026 | Election of Directors: John Lilly Director Elections |
Board | For | WITHHOLD 2 funds |
FOR 1 fund |
| Figma, Inc. | June 2, 2026 | Election of Directors: Lynn Vojvodich Radakovich Director Elections |
Board | For | WITHHOLD 2 funds |
FOR 1 fund |
| Fomento Economico Mexicano SAB de CV | March 27, 2026 | Elect Alfonso Garza Garza as Director Director Elections |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| Fomento Economico Mexicano SAB de CV | March 27, 2026 | Elect Bertha Paula Michel Gonzalez as Director Director Elections |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| Fomento Economico Mexicano SAB de CV | March 27, 2026 | Elect Board Chair and Secretaries; Approve Remuneration of Directors; Verify Director's Independence Classification Director Elections |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| Fomento Economico Mexicano SAB de CV | March 27, 2026 | Elect Eva Maria Garza Laguera Gonda as Director Director Elections |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| Fomento Economico Mexicano SAB de CV | March 27, 2026 | Elect Francisco Jose Calderon Rojas as Director Director Elections |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| Fomento Economico Mexicano SAB de CV | March 27, 2026 | Elect Jose Antonio Fernandez Carbajal as Director Director Elections |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| Fomento Economico Mexicano SAB de CV | March 27, 2026 | Elect Mariana Garza Laguera Gonda as Director Director Elections |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| Fomento Economico Mexicano SAB de CV | March 27, 2026 | Elect Paulina Garza Laguera Gonda as Director Director Elections |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| IGO Ltd. | November 19, 2025 | Approve Issuance of Service Rights to Ivan Vella Compensation |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| IGO Ltd. | November 19, 2025 | Approve Remuneration Report Compensation |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| IMMUNEERING CORPORATION | June 11, 2026 | Ratify the appointment of RSM US LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 1 fund |
ABSTAIN 1 fund |
| IMMUNOCORE HOLDINGS PLC | May 27, 2026 | To approve our directors' remuneration report for the year ended December 31, 2025, which is set forth as Annex A to the attached proxy statement and on pages 26 to 56 of the 2025 U.K. Annual Report (excluding the directors' remuneration policy set out on 26 to 56 2025 U.K. Annual Report (excluding the directors' remuneration policy set out on A7 to A18 of Annex A). Say-on-Pay |
Board | For | AGAINST 1 fund |
ABSTAIN 1 fund |
| IMMUNOCORE HOLDINGS PLC | May 27, 2026 | To approve, on advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. Say-on-Pay |
Board | For | AGAINST 1 fund |
ABSTAIN 1 fund |
| IMMUNOCORE HOLDINGS PLC | May 27, 2026 | To authorize the audit committee to determine the U.K. statutory auditors' remuneration for the year ending 31 December 2026. Audit-related |
Board | For | FOR 1 fund |
ABSTAIN 1 fund |
| IMMUNOCORE HOLDINGS PLC | May 27, 2026 | To ratify the appointment of Deloitte LLP, a limited liability partnership organized under the laws of England, as our U.S. independent registered public accounting firm for the year ending 31 December 2026. Audit-related |
Board | For | FOR 1 fund |
ABSTAIN 1 fund |
| IMMUNOCORE HOLDINGS PLC | May 27, 2026 | To re-appoint Deloitte LLP, a limited liability partnership organized under the laws of England, as our U.K. statutory auditors, to hold office until the conclusion of the next annual general meeting of shareholders. Audit-related |
Board | For | FOR 1 fund |
ABSTAIN 1 fund |
| IMMUNOCORE HOLDINGS PLC | May 27, 2026 | To re-appoint Kristine Peterson as a director who retires in accordance with the articles of association. Kristine Peterson Director Elections |
Board | For | AGAINST 1 fund |
ABSTAIN 1 fund |
| IMMUNOCORE HOLDINGS PLC | May 27, 2026 | To re-appoint Siddharth Kaul as a director who retires in accordance with the articles of association. Siddharth Kaul Director Elections |
Board | For | FOR 1 fund |
ABSTAIN 1 fund |
| IMMUNOCORE HOLDINGS PLC | May 27, 2026 | To re-appoint William Pao, M.D., Ph.D. as a director who retires in accordance with the articles of association. William Pao, M.D., Ph.D. Director Elections |
Board | For | FOR 1 fund |
ABSTAIN 1 fund |
| International Bancshares Corporation | May 18, 2026 | ELECTION OF DIRECTORS: R. R. Resendez Director Elections |
Board | For | FOR 21 funds |
ABSTAIN 1 fund |
| KLAVIYO, INC. | June 9, 2026 | To approve, on a non-binding advisory basis, the compensation of Klaviyo's named executive officers. Say-on-Pay |
Board | For | FOR 2 funds |
ABSTAIN 2 funds |
| KLAVIYO, INC. | June 9, 2026 | To ratify the appointment of Deloitte & Touche LLP as Klaviyo's independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 2 funds |
ABSTAIN 2 funds |
| MAXCYTE, INC. | June 17, 2026 | To ratify the Audit Committee's selection of CohnReznick LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 9 funds |
ABSTAIN 1 fund |
| Midea Group Co., Ltd. | September 24, 2025 | Approve Provision of Guarantees Capital Structure |
Board | For | AGAINST 1 fund |
FOR 2 funds |
| NKARTA, INC. | June 10, 2026 | Advisory approval of the compensation paid to the company's named executive officers, as disclosed in the proxy statement. Say-on-Pay |
Board | For | FOR 9 funds |
ABSTAIN 1 fund |
| NKARTA, INC. | June 10, 2026 | Ratification of the appointment of Ernst & Young LLP as the company's independent registered public accounting firm for the year ending December 31, 2026. Audit-related |
Board | For | FOR 9 funds |
ABSTAIN 1 fund |
| OPTIMIZERX CORPORATION | June 9, 2026 | Advisory (non-binding) approval of the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 9 funds |
ABSTAIN 1 fund |
| OPTIMIZERX CORPORATION | June 9, 2026 | Approval of an amendment to the 2021 Equity Plan to adopt an evergreen provision providing for an automatic annual increase in the shares of Common Stock available for issuance under the 2021 Equity Plan. Compensation |
Board | For | AGAINST 9 funds |
ABSTAIN 1 fund |
| OPTIMIZERX CORPORATION | June 9, 2026 | Ratification of Grant Thornton LLP as OptimizeRx's independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 9 funds |
ABSTAIN 1 fund |
| ORGANOGENESIS HOLDINGS INC | June 15, 2026 | Appointment of RSM US LLP as independent registered public accounting firm for fiscal year 2026. Audit-related |
Board | For | FOR 9 funds |
ABSTAIN 1 fund |
| ORGANOGENESIS HOLDINGS INC | June 15, 2026 | Approval, on an advisory basis, of the compensation paid to our named executive officers, as disclosed in the Company's proxy statement for its 2026 annual meeting of shareholders. Say-on-Pay |
Board | For | FOR 9 funds |
ABSTAIN 1 fund |
| Pacific Biosciences of California, Inc. | June 3, 2026 | Election of Directors: Kathy Ordonez Director Elections |
Board | For | FOR 10 funds |
ABSTAIN 1 fund |
| Pacific Metals Co., Ltd. | June 24, 2026 | Elect Director Iwadate, Kazuo Director Elections |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| Power Grid Corporation of India Limited | August 26, 2025 | Elect Sajal Jha as Director Director Elections |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| Power Grid Corporation of India Limited | August 26, 2025 | Elect Shiv Tapasya Paswan as Director Director Elections |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| Resources Connection, Inc. | October 16, 2025 | Election of Directors: Filip J. L. Gyde Director Elections |
Board | For | FOR 9 funds |
ABSTAIN 1 fund |
| SERVICETITAN, INC. | June 17, 2026 | To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our fiscal year ending January 31, 2027. Audit-related |
Board | For | FOR 1 fund |
ABSTAIN 2 funds |
| SIBANYE STILLWATER LIMITED | May 28, 2026 | Approve Financial Assistance in Terms of Sections 44 and 45 of the Companies Act Extraordinary Transactions |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| SKILLSOFT CORP. | June 25, 2026 | To approve, on an advisory basis, the compensation of our named executive officers; Say-on-Pay |
Board | For | FOR 9 funds |
AGAINST 1 fund |
| SLEEP NUMBER CORPORATION | May 21, 2026 | Advisory Vote to Approve Executive Compensation (Say on Pay) Say-on-Pay |
Board | For | FOR 9 funds |
ABSTAIN 1 fund |
| SLEEP NUMBER CORPORATION | May 21, 2026 | Approve Amendment to the Sleep Number Corporation 2020 Equity Incentive Plan to increase the number of shares reserved for issuance by 2,500,000 shares Compensation |
Board | For | AGAINST 9 funds |
ABSTAIN 1 fund |
| SLEEP NUMBER CORPORATION | May 21, 2026 | Ratification of Appointment of Independent Registered Public Accounting Firm Audit-related |
Board | For | FOR 9 funds |
ABSTAIN 1 fund |
| STARZ ENTERTAINMENT CORP. | May 15, 2026 | Advisory Vote on Executive Compensation: To pass a non-binding advisory resolution to approve the compensation of the Company's Named Executive Officers. See the section entitled ''Proposal 4 Advisory Vote to Approve Executive Compensation'' in the Notice and Proxy Statement. Say-on-Pay |
Board | For | FOR 9 funds |
ABSTAIN 1 fund |
| STARZ ENTERTAINMENT CORP. | May 15, 2026 | Appointment of Auditors: To reappoint Ernst & Young LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2026 at a remuneration to be determined by the directors. See the section entitled ''Proposal 2 Re-Appointment of Independent Registered Public Accounting Firm'' in the Notice and Proxy Statement. Audit-related |
Board | For | FOR 9 funds |
WITHHOLD 1 fund |
| STARZ ENTERTAINMENT CORP. | May 15, 2026 | Election of Directors: Bruce Mann Director Elections |
Board | For | FOR 9 funds |
WITHHOLD 1 fund |
| STARZ ENTERTAINMENT CORP. | May 15, 2026 | Election of Directors: Ed Wilson Director Elections |
Board | For | FOR 9 funds |
WITHHOLD 1 fund |
| STARZ ENTERTAINMENT CORP. | May 15, 2026 | Election of Directors: Emily Fine Director Elections |
Board | For | FOR 9 funds |
WITHHOLD 1 fund |
| STARZ ENTERTAINMENT CORP. | May 15, 2026 | Election of Directors: Hardwick Simmons Director Elections |
Board | For | FOR 9 funds |
WITHHOLD 1 fund |
| STARZ ENTERTAINMENT CORP. | May 15, 2026 | Election of Directors: Jeffrey A. Hirsch Director Elections |
Board | For | FOR 9 funds |
WITHHOLD 1 fund |
| STARZ ENTERTAINMENT CORP. | May 15, 2026 | Election of Directors: Joshua Sapan Director Elections |
Board | For | FOR 9 funds |
WITHHOLD 1 fund |
| STARZ ENTERTAINMENT CORP. | May 15, 2026 | Election of Directors: Lisa Gersh Director Elections |
Board | For | FOR 9 funds |
WITHHOLD 1 fund |
| STARZ ENTERTAINMENT CORP. | May 15, 2026 | Election of Directors: Mark H. Rachesky, M.D. Director Elections |
Board | For | FOR 9 funds |
WITHHOLD 1 fund |
| STARZ ENTERTAINMENT CORP. | May 15, 2026 | Election of Directors: Michael Burns Director Elections |
Board | For | FOR 9 funds |
WITHHOLD 1 fund |
| STARZ ENTERTAINMENT CORP. | May 15, 2026 | Election of Directors: Mignon Clyburn Director Elections |
Board | For | FOR 9 funds |
WITHHOLD 1 fund |
| STARZ ENTERTAINMENT CORP. | May 15, 2026 | Election of Directors: Ramin Arani Director Elections |
Board | For | FOR 9 funds |
WITHHOLD 1 fund |
| STE VIRBAC SA | June 29, 2026 | Approve Remuneration Policy of Paul Martingell, CEO Say-on-Pay |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| TREACE MEDICAL CONCEPTS, INC. | May 19, 2026 | Approval, on an advisory, non-binding basis, of the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 9 funds |
ABSTAIN 1 fund |
| TREACE MEDICAL CONCEPTS, INC. | May 19, 2026 | Ratification of the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 9 funds |
ABSTAIN 1 fund |
| VERONA PHARMA PLC | September 24, 2025 | To approve, on an advisory, non-binding basis, the compensation that may be paid or become payable to the Company's named executive officers in connection with the Transaction, as disclosed in the table entitled "Potential Payments to Named Executive Officers" beginning on page 70 of the proxy statement, including the associated narrative discussion, and the agreements or understandings pursuant to which such compensation may be paid or become payable. Say-on-Pay |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| VOR BIOPHARMA INC. | June 11, 2026 | To approve the amendment and restatement of our Amended and Restated 2021 Equity Incentive Plan. Compensation |
Board | For | AGAINST 1 fund |
ABSTAIN 1 fund |
| VOR BIOPHARMA INC. | June 11, 2026 | To ratify the selection by the audit committee of the board of directors of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 1 fund |
ABSTAIN 1 fund |
| WEG SA | April 23, 2026 | Approve Classification of Dan Ioschpe as Independent Director Director Elections |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| WEG SA | April 23, 2026 | Elect Directors Director Elections |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| ZHEJIANG HUAYOU COBALT CO LTD | April 28, 2026 | Approve Authorization on Financing Credit Extraordinary Transactions |
Board | For | FOR 1 fund |
AGAINST 1 fund |
Page 1 of 1
How items are matched and positions counted: see the comparison table and the methodology. Built October 13, 2026 from SEC Form N-PX filings.